Cresco Labs Inc. Press Releases https://investors.crescolabs.com/generated by Q4Tue, 12 May 2026 06:22:48 -0400Copyright Q4 Inc. All rights reserved.Cresco Labs Provides Update on Texas License Previously Awarded by Texas Department of Public Safety685505e9-7918-4dd1-95b0-d5c55ac25704https://investors.crescolabs.com/news/news-details/2026/Cresco-Labs-Provides-Update-on-Texas-License-Previously-Awarded-by-Texas-Department-of-Public-Safety/default.aspxMon, 11 May 2026 06:30:00 -0400Cresco Labs Reports First Quarter 2026 Financial Results, Advances Multiple Growth Initiativesb0a3b898-fa46-4c18-a3d2-d2401abfe459https://investors.crescolabs.com/news/news-details/2026/Cresco-Labs-Reports-First-Quarter-2026-Financial-Results-Advances-Multiple-Growth-Initiatives/default.aspxFri, 08 May 2026 06:30:00 -0400Cresco Labs Opens Sunnyside Aberdeen, Marking Second Ohio Dispensary Opening in a Monthc46da18c-ad8d-484f-98b5-051ee262941ehttps://investors.crescolabs.com/news/news-details/2026/Cresco-Labs-Opens-Sunnyside-Aberdeen-Marking-Second-Ohio-Dispensary-Opening-in-a-Month/default.aspxTue, 05 May 2026 06:30:00 -0400Cresco Labs CEO: Rescheduling Ushers in a New Era of Care for Medical Cannabis Patients4d5c5090-6581-43e3-b6c4-595f7c048a04https://investors.crescolabs.com/news/news-details/2026/Cresco-Labs-CEO-Rescheduling-Ushers-in-a-New-Era-of-Care-for-Medical-Cannabis-Patients/default.aspxThu, 23 Apr 2026 13:24:00 -0400Cresco Labs to Report First Quarter 2026 Financial Results on May 8, 20260d5dfa6c-16a2-4c49-b9de-9f29b522915chttps://investors.crescolabs.com/news/news-details/2026/Cresco-Labs-to-Report-First-Quarter-2026-Financial-Results-on-May-8-2026/default.aspxThu, 23 Apr 2026 06:30:00 -0400Cresco Labs Opens Sunnyside Bridgeport, Expanding Access in the Ohio Valley63900a45-9591-4b31-8648-8b7d19d1e1c5https://investors.crescolabs.com/news/news-details/2026/Cresco-Labs-Opens-Sunnyside-Bridgeport-Expanding-Access-in-the-Ohio-Valley/default.aspxFri, 10 Apr 2026 06:30:00 -0400Cresco Labs Awarded Texas Medical Cannabis License4a15d93e-080a-4390-b688-524b39e9cabbhttps://investors.crescolabs.com/news/news-details/2026/Cresco-Labs-Awarded-Texas-Medical-Cannabis-License/default.aspxThu, 02 Apr 2026 14:26:00 -0400Cresco Labs Delivers Q4 2025 Revenue of $162 Million and Sequential Margin Improvementd6576cab-0352-4828-8793-112f9409ac2bhttps://investors.crescolabs.com/news/news-details/2026/Cresco-Labs-Delivers-Q4-2025-Revenue-of-162-Million-and-Sequential-Margin-Improvement/default.aspxThu, 05 Mar 2026 06:30:00 -0500Cresco Labs to Report Fourth Quarter 2025 Financial Results on March 5, 20265feed329-3a37-4167-8fdd-c44b5c6eee07https://investors.crescolabs.com/news/news-details/2026/Cresco-Labs-to-Report-Fourth-Quarter-2025-Financial-Results-on-March-5-2026/default.aspxMon, 23 Feb 2026 06:30:00 -0500Cresco Labs Establishes At-the-Market Offering720e082a-6aaa-4331-b8c2-ed4747605e14https://investors.crescolabs.com/news/news-details/2026/Cresco-Labs-Establishes-At-the-Market-Offering/default.aspxFri, 30 Jan 2026 06:30:00 -0500